Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 1/20 | 0.50 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.50 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28248657 | 0.88 | BBOX1 (0.46) | BBOX1EHMT2EHMT1TSHRF2 | |
| Benzene Selenoic Acid SCHEMBL11047165 | 0.88 | BBOX1 (0.73) | BBOX1EHMT2EHMT1F2LMNA | |
| SCHEMBL6901728 | 0.78 | BBOX1 (0.52) | BBOX1EHMT2EHMT1TSHRF2 | |
| SCHEMBL28188957 | 0.72 | BBOX1 (0.41) | BBOX1EHMT2EHMT1TSHRALDH1A1 | |
| SCHEMBL10866379 | 0.72 | BBOX1 (0.41) | BBOX1EHMT2EHMT1LTA4HTSHR | |
| SCHEMBL7379226 | 0.71 | — | — | |
| SCHEMBL158572 | 0.71 | BBOX1 (0.58) | BBOX1EHMT2EHMT1TSHRLMNA | |
| Benzene Selenoic Acid SCHEMBL1440596 | 0.67 | — | — | |
| SCHEMBL3142465 | 0.67 | — | — | |
| Benzene Selenoic Acid SCHEMBL8752793 | 0.65 | BBOX1 (0.50) | BBOX1EHMT2EHMT1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12176507-B2 | Ink compositions | DOVER EUROPE SÀRL (CH) | 2024-12-24 | — | — | US | claimed |
| EP-4127084-B1 | METHOD FOR PREPARING PYRROLE POLYMERS | DOVER EUROPE SARL (CH) | 2024-06-19 | — | — | EP | claimed |
| EP-4127084-A2 | INK COMPOSITIONS | Dover Europe Sàrl (CH) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198360-A2 | INK COMPOSITIONS | DOVER EUROPE SARL (CH) | 2021-10-07 | — | — | WO | claimed |
| WO-2018109622-A1 | PROCESS FOR PREPARATION OF DYDROGESTERONE | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2018-06-21 | — | — | WO | claimed |
| US-RE41366-E1 | Total synthesis of galanthamine, analogues and derivatives thereof | CENTRE NATIONAL DEL LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2010-06-01 | — | — | US | claimed |
| US-20090312238-A1 | Protection Against Oxidative Damage in Cells | FLORIDA ATLANTIC UNIVERSITY (US) | 2009-12-17 | — | — | US | claimed |
| WO-2007130575-A2 | PROTECTION AGAINST OXIDATIVE DAMAGE IN CELLS | FLORIDA ATLANTIC UNIVERSITY (US) | 2007-11-15 | — | — | WO | claimed |
| EP-1458724-B1 | TOTAL SYNTHESIS OF GALANTHAMINE, ANALOGUES AND DERIVATIVES THEREOF | CENTRE NAT RECH SCIENT (FR) | 2007-08-15 | — | — | EP | claimed |
| US-7109327-B2 | Oxidizing agent mixed with a support starting from 8-methoxy-3,4,4a,8a-tetrahydro-spiro-chromen-2-one-[4,4']-cyclohex-2',5'-dien-1'-one to a spirodienone yields 1.6 (+-)-11-oxonarwedine or (+-)-6-methoxy-10-methyl-galantham-1-ene-3,11-dione; treating Alzheimer's disease | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2006-09-19 | — | — | US | claimed |
| WO-2005075497-A1 | PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES | RANBAXY LABORATORIES LIMITED (IN) | 2005-08-18 | — | — | WO | claimed |
| US-20050065338-A1 | Total synthesis of galanthamine, analogues and derivatives thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2005-03-24 | — | — | US | claimed |
| EP-0257631-A2 | Oxolabdanes, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-03-02 | — | — | EP | claimed |
| EP-0065468-B1 | DEHYDROGENATION AGENT CONTAINING ORGANIC SELENIUM DERIVATIVES AND THEIR USE IN THE 1,4-DEHYDROGENATION OF STEROIDS | ROUSSEL-UCLAF (FR) | 1985-04-24 | — | — | EP | claimed |
| US-4434080-A | DIOXYIODO AROMATICS | ROUSSEL UCLAF (FR) | 1984-02-28 | — | — | US | claimed |
| EP-4424787-B1 | METHOD FOR PREPARING PYRROLE POLYMERS | DOVER EUROPE SARL (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-12570687-B2 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | NUCMITO PHARMACEUTICALS CO. LTD. (CN) | 2026-03-10 | — | — | US | disclosed |
| US-4220588-A | PREPARATION OF ALPHA, BETA-UNSATURATED ALDEHYDE OR KETONE BY DEHYOROGENATING WITH ARYLSELENINIC ANHYDRIDE | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC., 49 AMHERST ST., CAMBRIDGE, MA. 02142, | 1980-09-02 | — | — | US | disclosed |
| US-4220588-A | PREPARATION OF ALPHA, BETA-UNSATURATED ALDEHYDE OR KETONE BY DEHYOROGENATING WITH ARYLSELENINIC ANHYDRIDE | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC., 49 AMHERST ST., CAMBRIDGE, MA. 02142, | 1980-09-02 | — | — | US | disclosed |
| US-4206131-A | 1A-HYDROXYLATED CALCIFEROLS | THE UPJOHN COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570687-B2 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | NR5A1, NR0B1, OXER1 | BBOX1 1307/4885EHMT2 4063/4885EHMT1 2535/4885 |
| US-20050065338-A1 | Total synthesis of galanthamine, analogues and derivatives thereof | GALR1, GALR3, GALR2 | BBOX1 851/4885EHMT2 1170/4885EHMT1 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.